Laryngeal Cancer Overview
Learn About Laryngeal Cancer
Johns Hopkins Outpatient Center
Christine Gourin, M.D. M.P.H., is a head and neck surgical oncologist and palliative medicine specialist who treats patients with head and neck tumors, including tumors of the skin, melanoma, oral cavity, larynx, oropharynx, neck, salivary glands, sinuses, and skull base. Dr. Gourin received her medical degree from the State University of New York-Health Science Center at Brooklyn/Downstate Medical Center. Dr. Gourin trained in General Surgery and Otolaryngology-Head and Neck Surgery at the University of Vermont, followed by a fellowship in Advanced Head and Neck Oncologic Surgery at the University of Pittsburgh and a fellowship in Hospice and Palliative Medicine at Johns Hopkins University. She has authored over 200 peer-reviewed journal articles, 24 book chapters and two books: Medical and Surgical Management of Thyroid and Parathyroid Diseases and The Johns Hopkins Patient Guide to Head and Neck Cancer. She is on the Editorial Board of The Laryngoscope and is a reviewer for numerous other head and neck surgery journals. Dr. Gourin is a nationally and internationally recognized expert in quality of care and outcomes with a lifelong interest in improved symptom management, communication, access to high-quality affordable care, and palliative medicine in head and neck cancer. She has an active head and neck surgical oncology practice and has been named to America’s Top Physicians and Best Doctors in America annually since 2005. She is the Director of the Johns Hopkins Head and Neck Cancer Supportive Care Clinic. Dr. Gourin is rated as an Elite provider by MediFind in the treatment of Laryngeal Cancer. Her top areas of expertise are Laryngeal Cancer, Throat Cancer, Tongue Cancer, Laryngectomy, and Gastrostomy.
Cleveland Clinic Main Campus
Joseph Scharpf is an Otolaryngologist in Cleveland, Ohio. Dr. Scharpf has been practicing medicine for over 32 years and is rated as an Elite provider by MediFind in the treatment of Laryngeal Cancer. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Human Papillomavirus Infection, Thyroidectomy, and Laryngectomy.
Univ. Ear Nose & Throat Specialists - Eye And Ear Inst.
Matthew E. Spector, MD, FACS, completed his medical school training at Stritch School of Medicine, Loyola University in Chicago. He then went on to the University of Michigan where he completed his residency in Otolaryngology – Head and Neck Surgery and fellowship in Head and Neck Surgical Oncology and Microvascular Reconstruction. He was on faculty at the University of Michigan for 10 years where he served as the Director of the Head and Neck Oncology Program and Associate Director of the Head and Neck Surgical Oncology and Microvascular Reconstruction Fellowship. Dr. Spector is rated as an Elite provider by MediFind in the treatment of Laryngeal Cancer. His top areas of expertise are Throat Cancer, Laryngeal Cancer, Tongue Cancer, Laryngectomy, and Glossectomy.
Summary: This phase II trial compares the effectiveness of cemiplimab with CDX-1140 to cemiplimab without CDX-1140 prior to surgery in treating patients with stage III-IV head and neck cancer. Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. CDX-1140 is a monoclonal antibo...
Summary: This phase II trial studies the good and bad effects of the combination of drugs called cabozantinib and nivolumab in treating patients with melanoma or squamous cell head and neck cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for ...


